Competition of 83 products in the market of the depression treatment, ‘fluoxetine’

Published: 2015-07-10 14:19:42

Updated: 2015-07-10 14:24:09

It is known that 83 products have been competing over the domestic depression treatment ‘fluoxetine hydrochloride.’

According to the Ministry of Food and Drug Safety, fluctuation is expected in the domestic market as the patent of ‘fluoxetine hydrochloride,’ the main substance of Prozac owned by Lilly Korea, is going to be expired on the 20^th.

The product fluoxetine hydrochloride was first do...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.